References
- Grant RN: Yogurt and buttermilk in cancer management. JAMA 210, 1769–1770, 1969.
- Sprong RC, Hulstein MFE, Lambers TT, and Van der Mee R: Sweet buttermilk intake reduces colonisation and translocation of Listeria monocytogenes in rats by inhibiting mucosal pathogen adherence. BJN 108, 2026–2033, 2012.
- Conway V, Couture P, Richard C, Gauthier S, Pouliot Y, et al.: Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women. NMCD 23, 1255–1262, 2013.
- Conway V, Couture P, Gauthier S, Pouliot Y, and Lamarche B: Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women. Nutrition 30, 116–119, 2014.
- Snow DR, Jimenez-Flores R, Ward RE, Cambell J, Young MJ, et al.: Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in fischer-344 rats. J Agric Food Chem 58, 2157–2163, 2010.
- Dewettinck K, Rombaut R, Thienpont N, Le TT, Messens K, et al.: Nutritional and technological aspects of milk fat globule membrane material. Int Dairy J 18, 436–457, 2008.
- Spitsberg VL: Bovine milk fat globule membrane as a potential nutraceutical. J Dairy Sci 88, 2289–2294, 2005.
- Kuchta AM, Kelly PM, Stanton C, and Devery RA: Milk fat globule membrane-a source of polar lipids for colon health? Int J Dairy Technol 65, 315–333, 2012.
- Dillehay DL, Webb SK, Schmelz EM, and Merrill AH: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124, 615–620, 1994.
- Schmelz EM, Sullards MC, Dillehay DL, and Merrill AH: Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. J Nutr 130, 522–527, 2000.
- Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, et al.: Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 419, 129–138, 2003.
- Zanabria R, Tellez AM, Griffiths MW, and Corredig M: The antiproliferative properties of the milk fat globule membrane are affected by extensive heating. Dairy Sci Technol 94, 439–453, 2014.
- Jenness R and Koops J: Preparation and properties of a salt solution which simulates milk ultrafiltrate. Nederlands melk-en zuiveltijdschrift 16, 153–164, 1962.
- Rombaut R, Camp JV, and Dewettinck K: Analysis of phospho- and sphingolipids in dairy products by a new HPLC method. J Dairy Sci 88, 482–488, 2005.
- McBain JA, Eastman A, Nobel CS, and Mueller GC: Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 53, 1357–1368, 1997.
- O'Connor R, Heenan M, and Duffy C: Miniaturised in vitro assays in toxicity testing. In Animal cell culture techniques, ed. M. Clynes, Berlin, New York: Springer, 1998, 423–433.
- Morin P, Jimenez-Flores R, and Pouliot Y: Effect of processing on the composition and microstructure of buttermilk and its milk fat globule membranes. Int Dairy J 17, 1179–1187, 2007.
- Bektas M and Spiegel S: Glycosphingolipids and cell death. Glycoconjugate J 20, 39–47, 2003.
- Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, et al.: Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129, 1239–1250, 1999.
- Wang Y K, Zhu YL, Qiu FM, Zhang T, Chen ZG et al.: Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+primary colon cancer cells. Carcinogenesis 31, 1376–1380, 2010.
- Rice PL, Washington M, Schleman S, Scott Beard K, Driggers LJ et al.: Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and bad in human colon cancer cells. Can Res 63, 616–620, 2003.
- Krausova M and Korinek V: Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling 26, 570–579, 2014.
- Polakis P: The oncogenic activation of beta-catenin. Curr Opin Gen Dev 9, 15–21, 1999.
- Martensson A, Oberg A, Jung A, Cederquist K, Stenling R et al.: Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer. Oncology Reports: 17, 447–452, 2007.
- Schmelz EM, Roberts PC, Kustin EM, Lemonnier LA, Sullards MC et al.: Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Can Res 61, 6723–6729, 2001.
- Simon KW, Roberts PC, Vespremi MJ, Manchen S, and Schmelz EM: Regulation of beta-catenin and connexin-43 expression: Targets for sphingolipids in colon cancer prevention. Mol Nut Food Res 53, 332–340, 2009.